APT Medical Closes $191 Million Shanghai STAR Board IPO

APT Medical completed a $191 million IPO on the Shanghai STAR Exchange, rising 245% in its first trading session to a market cap of $2.7 billion. Founded in 2002, the company makes a variety of affordable catheters for cardiovascular conditions. Its offerings include coronary artery access and electrophysiological products, plus peripheral blood vessels and nerve intervention medical products. APT claims to have the largest China market share among domestic electrophysiological medical device companies. Qiming Ventures was an early investor with a 19% stake in the company after the IPO. More details.... Stock Symbol: (SHA: 688617) Share this with colleagues: // //